Gorbach SL - Search Results

1

A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation.

Mullane KM, Winston DJ, Nooka A, Morris MI, Stiff P, Dugan MJ, Holland H, Gregg K, Adachi JA, Pergam SA, Alexander BD, Dubberke ER, Broyde N, Gorbach SL, Sears PS. Mullane KM, et al. Among authors: gorbach sl. Clin Infect Dis. 2019 Jan 7;68(2):196-203. doi: 10.1093/cid/ciy484. Clin Infect Dis. 2019. PMID: 29893798 Free PMC article. Clinical Trial.

2

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.

Mullane KM, Miller MA, Weiss K, Lentnek A, Golan Y, Sears PS, Shue YK, Louie TJ, Gorbach SL. Mullane KM, et al. Among authors: gorbach sl. Clin Infect Dis. 2011 Sep;53(5):440-7. doi: 10.1093/cid/cir404. Clin Infect Dis. 2011. PMID: 21844027 Free PMC article.

3

Fidaxomicin versus vancomycin for Clostridium difficile infection.

Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK; OPT-80-003 Clinical Study Group. Louie TJ, et al. N Engl J Med. 2011 Feb 3;364(5):422-31. doi: 10.1056/NEJMoa0910812. N Engl J Med. 2011. PMID: 21288078 Free article. Clinical Trial.

4

Fidaxomicin: first-in-class macrocyclic antibiotic.

Mullane KM, Gorbach S. Mullane KM, et al. Expert Rev Anti Infect Ther. 2011 Jul;9(7):767-77. doi: 10.1586/eri.11.53. Expert Rev Anti Infect Ther. 2011. PMID: 21810048 Review.

5

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.

Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, Sears P, Gorbach S; OPT-80-004 Clinical Study Group. Cornely OA, et al. Lancet Infect Dis. 2012 Apr;12(4):281-9. doi: 10.1016/S1473-3099(11)70374-7. Epub 2012 Feb 8. Lancet Infect Dis. 2012. PMID: 22321770 Clinical Trial.

6

Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic.

Sears P, Ichikawa Y, Ruiz N, Gorbach S. Sears P, et al. Ann N Y Acad Sci. 2013 Jul;1291:33-41. doi: 10.1111/nyas.12135. Epub 2013 May 14. Ann N Y Acad Sci. 2013. PMID: 23672600 Review.

7

Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.

Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S. Cornely OA, et al. J Clin Oncol. 2013 Jul 1;31(19):2493-9. doi: 10.1200/JCO.2012.45.5899. Epub 2013 May 28. J Clin Oncol. 2013. PMID: 23715579 Clinical Trial.

8

Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.

Mullane KM, Cornely OA, Crook DW, Golan Y, Louie TJ, Miller MA, Josephson MA, Gorbach SL. Mullane KM, et al. Among authors: gorbach sl. Am J Nephrol. 2013;38(1):1-11. doi: 10.1159/000351757. Epub 2013 Jun 20. Am J Nephrol. 2013. PMID: 23796582

9

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea.

Weiss K, Louie T, Miller MA, Mullane K, Crook DW, Gorbach SL. Weiss K, et al. Among authors: gorbach sl. BMJ Open Gastroenterol. 2015 Mar 2;2(1):e000028. doi: 10.1136/bmjgast-2014-000028. eCollection 2015. BMJ Open Gastroenterol. 2015. PMID: 26462279 Free PMC article.

10

Response to Surawicz et al.

Gorbach S, DeRyke CA, Sears P. Gorbach S, et al. Am J Gastroenterol. 2014 Oct;109(10):1684. doi: 10.1038/ajg.2014.224. Am J Gastroenterol. 2014. PMID: 25287090 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page